AIG
TVRD

American International Group’s Tvardi Therapeutics TVRD Stock Holding History

American International Group’s Portfolio TVRD Stock Details TVRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-640
Closed -$21K – 2859
2024
Q1 		$21K Sell
640
-6
-0.9% -$156 ﹤0.01% 2924
2023
Q4 		$17.3K Sell
646
-2
-0.3% -$83 ﹤0.01% 2982
2023
Q3 		$39.2K Buy
648
+23
+4% +$2.16K ﹤0.01% 2880
2023
Q2 		$63.7K Sell
625
-55
-8% -$7.58K ﹤0.01% 2816
2023
Q1 		$120K Buy
680
+3
+0.4% +$1K ﹤0.01% 2373
2022
Q4 		$262K Sell
677
-5
-0.7% -$1.9K ﹤0.01% 1993
2022
Q3 		$230K Buy
682
+13
+2% +$4.71K ﹤0.01% 2078
2022
Q2 		$220K Sell
669
-33
-5% -$11.6K ﹤0.01% 2126
2022
Q1 		$307K Sell
702
-44
-6% -$18.1K ﹤0.01% 1993
2021
Q4 		$327K Sell
746
-23
-3% -$11.6K ﹤0.01% 2071
2021
Q3 		$428K Sell
769
-29
-4% -$14.5K ﹤0.01% 1969
2021
Q2 		$410 Buy
798
+132
+20% +$83.6K ﹤0.01% 2050
2021
Q1 		$521 Buy
666
+1
+0.2% +$685 ﹤0.01% 1817
2020
Q4 		$362 Sell
665
-19
-3% -$9.96K ﹤0.01% 1936
2020
Q3 		$313K Sell
684
-15
-2% -$8.71K ﹤0.01% 1852
2020
Q2 		$430K Buy
699
+44
+7% +$24.3K ﹤0.01% 1677
2020
Q1 		$311K Sell
655
-38
-5% -$20.6K ﹤0.01% 1666
2019
Q4 		$402K Sell
693
-5
-0.7% -$3.51K ﹤0.01% 1816
2019
Q3 		$460K Buy
698
+96
+16% +$79.8K ﹤0.01% 1713
2019
Q2 		$466K Buy
602
+25
+4% +$17.6K ﹤0.01% 1744
2019
Q1 		$408K Sell
577
-19
-3% -$11.4K ﹤0.01% 1832
2018
Q4 		$279K Sell
596
-4
-0.7% -$2.58K ﹤0.01% 1984
2018
Q3 		$518K Buy
600
+109
+22% +$78.7K ﹤0.01% 1876
2018
Q2 		$338K Buy
491
+17
+4% +$8.64K ﹤0.01% 2066
2018
Q1 		$211K Sell
474
-26
-5% -$12.6K ﹤0.01% 2228
2017
Q4 		$220K Buy
500
+2
+0.4% +$912 ﹤0.01% 2264
2017
Q3 		$245K Buy
498
+38
+8% +$19K ﹤0.01% 2175
2017
Q2 		$255K Buy
460
+101
+28% +$64.1K ﹤0.01% 2138
2017
Q1 		$238K Buy
359
+23
+7% +$12.3K ﹤0.01% 2074
2016
Q4 		$112K Hold
336
– – ﹤0.01% 2540
2016
Q3 		$101K Hold
336
– – ﹤0.01% 2590
2016
Q2 		$58.2K Buy
336
+15
+5% +$3.27K ﹤0.01% 2909
2016
Q1 		$72K Sell
321
-13
-4% -$3.88K ﹤0.01% 3650
2015
Q4 		$203K Hold
334
– – ﹤0.01% 2826
2015
Q3 		$172K Hold
334
– – ﹤0.01% 2971
2015
Q2 		$146K Buy
334
+178
+114% +$68.8K ﹤0.01% 3318
2015
Q1 		$56.6K Buy
156
+1
+0.6% +$378 ﹤0.01% 3913
2014
Q4 		$55.7K Sell
155
-4
-3% -$1.29K ﹤0.01% 3924
2014
Q3 		$48K Hold
159
– – ﹤0.01% 4005
2014
Q2 		$97.4K Buy
159
+98
+161% +$52.8K ﹤0.01% 3602
2014
Q1 		$40.9K Buy
+61
New +$36.1K ﹤0.01% 3907

Other funds holding TVRD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

American International Group's TVRD Position: Q2 2024 in Review

American International Group sold out of Tvardi Therapeutics (TVRD) in Q2 2024, closing a stake of 640 shares — an estimated $21K sold.

American International Group first reported a position in TVRD in Q1 2014 and held it in 41 quarters. The position peaked at $518K in Q3 2018. 79 funds tracked by Wall St. Rank hold TVRD as of Q2 2024.

  • American International Group reported no remaining Tvardi Therapeutics position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 640 Tvardi Therapeutics shares in Q2 2024, an estimated $21K.
  • American International Group first reported a position in Tvardi Therapeutics in Q1 2014 and held it in 41 quarters.
  • American International Group's Tvardi Therapeutics position peaked at $518K in Q3 2018.
  • 79 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.